Brief: Nordic Nanovector Signs Global Clinical And Commercial Agreement With ITM

Thor Medical ASA

07/10/2019 07:04

Oct 7 (Reuters) - Nordic Nanovector ASA  NANOV.OL :
    * NORDIC NANOVECTOR SIGNS GLOBAL CLINICAL AND COMMERCIAL
AGREEMENT
WITH ITM
    * NORDIC NANOVECTOR SIGNS GLOBAL CLINICAL AND COMMERCIAL
AGREEMENT
WITH ITM
    * HAS SIGNED A LONG-TERM GLOBAL SUPPLY AGREEMENT WITH A
SUBSIDIARY
OF ITM ISOTOPEN TECHNOLOGIEN MÜNCHEN AG (ITM), ISOTOPE
TECHNOLOGIES GARCHING GMBH (ITG)
    * SIGNS AGREEMENT TO ENSURE SUPPLY OF HIGH QUALITY,
NO-CARRIER-ADDED (N.C.A.) LUTETIUM-177, A KEY COMPONENT OF
BETALUTIN® ( 177 LU-LILOTOMAB-SATETRAXETAN) FOR RESEARCH AND
DEVELOPMENT, CLINICAL AND COMMERCIAL USES

Source text for Eikon:  ID:nObikVqhxa 
Further company coverage:  NANOV.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))